PolyPid Calls February 2026 Extraordinary Meeting to Approve Board Chair Compensation

The latest announcement is out from PolyPid ( (PYPD) ).

On December 31, 2025, PolyPid Ltd. reported that it has convened an Extraordinary General Meeting of Shareholders to be held on February 4, 2026, at its Petach Tikva headquarters, with a single agenda item: approval of the compensation terms of Ms. Brooke Story, chair of the company’s board of directors. Shareholders of record at the close of business on January 5, 2026, will be entitled to receive notice and vote, either in person or by proxy, with the board recommending support for the proposed resolution, underscoring the company’s focus on formalizing board leadership compensation as part of its ongoing corporate governance framework.

The most recent analyst rating on (PYPD) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on PolyPid stock, see the PYPD Stock Forecast page.

Spark’s Take on PYPD Stock

According to Spark, TipRanks’ AI Analyst, PYPD is a Neutral.

The score is held back primarily by weak financial fundamentals (no revenue, continued losses/cash burn, and financing risk). Offsetting this is a favorable earnings-call outlook with clear regulatory timelines and commercial readiness progress, while technicals show an uptrend but appear overbought. Valuation is difficult to anchor given negative earnings and no dividend.

To see Spark’s full report on PYPD stock, click here.

More about PolyPid

PolyPid Ltd. is an Israel-based company whose ordinary shares are listed in the United States as a foreign private issuer under the Securities Exchange Act of 1934. The company files annual reports on Form 20-F and uses F-3 and S-8 registration statements for its capital markets activities, indicating an orientation toward U.S. public equity and employee incentive markets.

Average Trading Volume: 83,984

Technical Sentiment Signal: Sell

Current Market Cap: $69.79M

Learn more about PYPD stock on TipRanks’ Stock Analysis page.